Publicaciones (222) Publicaciones en las que ha participado algún/a investigador/a

2017

  1. 18F-FDG PET/CT in the clinical management of patients with lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 312-321

  2. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors

    Clinical and Experimental Pharmacology and Physiology, Vol. 44, Núm. 12, pp. 1224-1231

  3. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit

    Journal of Clinical Virology, Vol. 95, pp. 76-83

  4. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

    Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106

  5. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

    Cancer Cell, Vol. 32, Núm. 5, pp. 608-623.e9

  6. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

    Stem Cell Reports, Vol. 9, Núm. 2, pp. 451-463

  7. A multicentric study to evaluate the use of relative retention times in targeted proteomics

    Journal of Proteomics, Vol. 152, pp. 138-149

  8. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357

  9. A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases

    Scientific Reports, Vol. 7, Núm. 1

  10. A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

    Oncotarget, Vol. 8, Núm. 42, pp. 73144-73153

  11. A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells

    Oncotarget, Vol. 8, Núm. 26, pp. 42836-42846

  12. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts

    Leukemia Research, Vol. 56, pp. 82-87

  13. APC/CCdh1 Enables Removal of Shugoshin-2 from the Arms of Bivalent Chromosomes by Moderating Cyclin-Dependent Kinase Activity

    Current Biology, Vol. 27, Núm. 10, pp. 1462-1476.e5

  14. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 4, pp. 764-769

  15. Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future

    Cancer Research, Vol. 77, Núm. 6, pp. 1261-1270

  16. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

    Oncotarget, Vol. 8, Núm. 39, pp. 64670-64684

  17. Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma

    Scientific Reports, Vol. 7, Núm. 1

  18. Antitumoral effect of ocoxin in hepatocellular carcinoma

    Oncology Letters, Vol. 14, Núm. 2, pp. 1950-1958

  19. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes

    Thrombosis and Haemostasis, Vol. 117, Núm. 1, pp. 66-74

  20. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7